Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Jun 2020 07:00

RNS Number : 6484P
Midatech Pharma PLC
11 June 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

 

Midatech Pharma Plc

 

Oddfellows House

19 Newport Road

Cardiff CF24 0AA

United Kingdom

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Acacia Research Corporation

City and country of registered office (if applicable)

Irvine, California, United States of America

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

09/06/2020

6. Date on which issuer notified (DD/MM/YYYY):

10/06/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.91%

9.91%

39,252,557

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares of £0.001 each

GB00BKT14T00

3,891,284

9.91%

SUBTOTAL 8. A

3,891,284

9.91%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Acacia Research

Corporation

9.91%

9.91%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

New York, New York, USA

Date of completion

09/06/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFBMITMTBBMAM
Date   Source Headline
5th Dec 20192:00 pmRNSEuro 2.6m Grant for clinical development of MTX110
5th Dec 20197:00 amRNSHolding(s) in Company
4th Nov 20195:41 pmRNSHolding(s) in Company
31st Oct 20196:12 pmRNSHolding(s) in Company
31st Oct 20199:26 amRNSHolding(s) in Company
28th Oct 20197:01 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSClosing of US$3.0m Registered Direct Offering
24th Oct 20197:00 amRNSMTX110 Receives Orphan Designation for DIPG
23rd Oct 20197:08 amRNSUS$3.0m Registered Direct Offering
17th Oct 20192:23 pmRNSHolding(s) in Company
15th Oct 20192:59 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSCommencement of MTD201 Phase 1 Study
7th Oct 20197:00 amRNSPDMR Dealing
7th Oct 20197:00 amRNSIssue of Equity for Employee Share Incentive Plan
4th Oct 20197:00 amRNSPDMR Dealing
3rd Oct 20197:00 amRNSPDMR Dealing
2nd Oct 201910:19 amRNSAward of Options to a Director
2nd Oct 20197:00 amRNSPDMR Dealing
30th Sep 20197:13 amRNSInterim Results
24th Sep 20197:00 amRNSFiling of U.S. Shelf Registration
20th Sep 20197:00 amRNSMTD201 Phase 1 Study Approval
11th Sep 201910:05 amRNSReceipt of Spanish Government Loan
9th Sep 20197:00 amRNSDirectorate Change
31st Jul 20197:00 amRNSAppointment of Non-Executive Director
19th Jul 20194:40 pmRNSSecond Price Monitoring Extn
19th Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jul 20197:00 amRNSMTX102 Safety Results
3rd Jul 20199:30 amRNSMTX110 Update
19th Jun 201912:00 pmRNSResult of AGM
13th Jun 20197:00 amRNSMTD201 Development Plan
24th May 20195:25 pmRNSPosting of Annual Report & Notice of AGM
7th May 20197:00 amRNSTurner Pope Investor Evening
26th Apr 20194:30 pmRNSReceipt of NASDAQ Notification
25th Apr 20194:40 pmRNSSecond Price Monitoring Extn
25th Apr 20194:35 pmRNSPrice Monitoring Extension
24th Apr 20194:40 pmRNSSecond Price Monitoring Extn
24th Apr 20194:35 pmRNSPrice Monitoring Extension
24th Apr 20192:05 pmRNSSecond Price Monitoring Extn
24th Apr 20192:00 pmRNSPrice Monitoring Extension
24th Apr 20197:00 amRNSFinal Results
5th Apr 201911:05 amRNSSecond Price Monitoring Extn
5th Apr 201911:00 amRNSPrice Monitoring Extension
29th Mar 20192:06 pmRNSSecond Price Monitoring Extn
29th Mar 20192:00 pmRNSPrice Monitoring Extension
29th Mar 20197:00 amRNSSpanish Government Loan Approval
20th Mar 20197:00 amRNSADR Ratio Change
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:36 pmRNSPrice Monitoring Extension
28th Feb 201911:05 amRNSSecond Price Monitoring Extn
28th Feb 201911:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.